POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.

New Jersey Bill A5730 Requires Pharmacies to Provide Emergency 30-Day Insulin Supplies

Original title: Requires pharmacies to provide emergency 30-day supply of insulin in certain circumstances.

Last action · October 29, 2026: Introduced, Referred to Assembly Financial Institutions and Insurance CommitteeSponsor: Heather Simmons

Companion · S 4759same policy, Senate version
Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

Assembly Bill 5730 requires New Jersey pharmacies to provide an emergency 30-day supply of insulin to eligible residents facing urgent medical need. Under the proposed legislation, uninsured or underinsured individuals who meet specific criteria can access the medication once every 12 months, with manufacturers required to reimburse pharmacies for the .

Why it matters

Residents experiencing severe insulin shortages without affordable insurance coverage gain temporary emergency access to medication, while pharmaceutical manufacturers face financial reimbursement obligations and potential civil penalties up to $100,000 per month for non-compliance.

Background
  • Heather Simmons is a member of the New Jersey General Assembly representing District 3. context
  • The New Jersey Legislature operates in biennial sessions, with Assembly Bill 5730 introduced during the 222nd legislative session. context

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

New Jersey residents with diabetes

Eligible residents facing an urgent insulin shortage can access a temporary 30-day emergency supply once per year under specific coverage conditions.

Directly affected

Pharmacies

Pharmacies must dispense emergency insulin supplies to eligible applicants and submit claims to manufacturers for acquisition cost reimbursement or product replacement.

Directly affected

Insulin manufacturers

Manufacturers must reimburse pharmacies for the acquisition cost of dispensed emergency insulin or supply product replacements, or face civil penalties up to $100,000 per month.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Who qualifies for an emergency 30-day supply of insulin under this bill?
New Jersey residents who have less than a seven-day supply of insulin, are not enrolled in NJ FamilyCare or similar medical assistance, and lack prescription drug coverage that caps 30-day insulin at $35 or less.
How often can a resident access this emergency supply?
Normally once in a 12-month period, unless the individual has applied for NJ FamilyCare and is awaiting eligibility determination or effective coverage, which permits a second emergency supply.
Who pays for the emergency insulin provided by the pharmacy?
The manufacturer of the dispensed insulin product or its vendor must either reimburse the pharmacy for its or send a direct replacement supply of the same insulin.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

1 action
  1. Oct 29, 2026HouseIntroduced
    Introduced, Referred to Assembly Financial Institutions and Insurance Committee

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

NJ FamilyCare Program, New Jersey State Board of Pharmacy, Department of Banking and Insurance and 1 more
OrganizationNJ FamilyCare Program“State medical assistance program referenced in eligibility criteria for emergenc”Map →
OrganizationNew Jersey State Board of Pharmacy“Collaborates with the Department of Banking and Insurance to develop the emergen”Map →
OrganizationDepartment of Banking and Insurance“Develops the emergency insulin application form, adopts rules, and assesses civi”Map →
PersonHeather Simmons“Assemblywoman sponsoring Assembly Bill 5730 representing District 3.”Map →

Sources

Open source document

njleg.state.nj.us

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy45
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz35
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record